Patents Assigned to LaZure Technologies, LLC
-
Patent number: 9603654Abstract: Electric field delivery and ablation of target tissue regions, including cancerous cells and solid tumors. Methods and systems include delivering an electric field to a target tissue, and may include positioning a first electrode or plurality to at least partially define a first treatment volume in the target tissue; positioning a second electrode or plurality to at least partially define a second treatment volume, the first volume is disposed in the second volume; and establishing a first current flow extending through the first volume and a second current flow extending through the second volume.Type: GrantFiled: October 2, 2013Date of Patent: March 28, 2017Assignee: LaZure Technologies, LLC.Inventor: Larry Azure
-
Patent number: 8915911Abstract: The present invention provides devices and systems, as well as methods, of electric field delivery and non-thermal or selective ablation of target tissue regions, including selective ablation of cancerous cells and solid tumors. A method of the present invention includes delivering an electric field to a tissue, including positioning an electrode within a target tissue region comprising cancerous cells, and applying an alternating electrical current to the target tissue so as to non-thermally ablate cancerous cells of the target tissue region around the electrodes.Type: GrantFiled: April 13, 2010Date of Patent: December 23, 2014Assignee: LaZure Technologies, LLCInventor: Larry Azure
-
Patent number: 8880195Abstract: Transurethral systems and methods for delivering electrical energy and controlled, mild heating to a prostate tissue of a patient for destruction of cancerous and/or hyperplastic tissue. A method includes positioning an elongate urethral probe having an expandable member with electrode elements at a target location in the patient's urethra, and inflating or expanding at the target location. Secondary electrodes are positioned within or adjacent to the prostate tissue and spaced from the electrode elements of the expandable member, and an alternating electrical current flow is established between the electrode elements of the expandable member and the one or more secondary electrodes. Current delivery can be selected so as to destroy or ablate cancerous cells of the prostate tissue.Type: GrantFiled: September 15, 2008Date of Patent: November 4, 2014Assignee: LaZure Technologies, LLCInventor: Larry Azure
-
Publication number: 20140303613Abstract: Devices, systems, and related methods for electric fields delivery for preferential destruction of cancerous cells and tissue ablation.Type: ApplicationFiled: March 31, 2014Publication date: October 9, 2014Applicants: LaZure Scientific, Inc., LaZure Technologies, LLCInventors: Larry Azure, Charles E. Hill, Andrew L. Azure
-
Patent number: 8728139Abstract: Devices, systems, and related methods for electric fields delivery for preferential destruction of cancerous cells and tissue ablation.Type: GrantFiled: April 16, 2010Date of Patent: May 20, 2014Assignees: LaZure Technologies, LLC, LaZure Scientific, Inc.Inventors: Larry Azure, Charles E. Hill, Andrew L. Azure
-
Publication number: 20140100565Abstract: Electric field delivery and ablation of target tissue regions, including cancerous cells and solid tumors. Methods and systems include delivering an electric field to a target tissue, and may include positioning a first electrode or plurality to at least partially define a first treatment volume in the target tissue; positioning a second electrode or plurality to at least partially define a second treatment volume, the first volume is disposed in the second volume; and establishing a first current flow extending through the first volume and a second current flow extending through the second volume.Type: ApplicationFiled: October 2, 2013Publication date: April 10, 2014Applicant: LaZure Technologies, LLC.Inventor: Larry Azure
-
Patent number: 8562602Abstract: Electric field delivery and ablation of target tissue regions, including cancerous cells and solid tumors. Methods and systems include delivering an electric field to a target tissue, and may include positioning a first electrode or plurality to at least partially define a first treatment volume in the target tissue; positioning a second electrode or plurality to at least partially define a second treatment volume, the first volume is disposed in the second volume; and establishing a first current flow extending through the first volume and a second current flow extending through the second volume.Type: GrantFiled: September 15, 2008Date of Patent: October 22, 2013Assignee: Lazure Technologies, LLCInventor: Larry Azure
-
Publication number: 20120232550Abstract: The present invention provides systems, devices and related methods for applying electric fields for cancerous cell destruction and tissue ablation. A method can include advancing an ablation probe into a patient; deploying a guide from the delivery member along a guide tissue penetration path, deploying an electrode from the guide along an electrode tissue penetration path, and establishing current flow within the target tissue.Type: ApplicationFiled: January 5, 2012Publication date: September 13, 2012Applicants: LaZure Technologies, LLC, LaZure Scientific, Inc.Inventor: Larry Azure
-
Patent number: 8109926Abstract: The present invention provides systems, devices and related methods for applying electric fields for cancerous cell destruction and tissue ablation. A method can include advancing an ablation probe into a patient; deploying a guide from the delivery member along a guide tissue penetration path, deploying an electrode from the guide along an electrode tissue penetration path, and establishing current flow within the target tissue.Type: GrantFiled: September 14, 2007Date of Patent: February 7, 2012Assignees: Lazure Scientific, Inc., Lazure Technologies, LLCInventor: Larry Azure
-
Publication number: 20110060393Abstract: Devices, systems, and related methods for electric fields delivery for preferential destruction of cancerous cells and tissue ablation.Type: ApplicationFiled: April 16, 2010Publication date: March 10, 2011Applicants: LaZure Technologies, LLC, LaZure Scientific, Inc.Inventors: Larry Azure, Charles E. Hill, Andrew L. Azure
-
Publication number: 20110015630Abstract: The present invention provides devices and systems, as well as methods, of electric field delivery and non-thermal or selective ablation of target tissue regions, including selective ablation of cancerous cells and solid tumors. A method of the present invention includes delivering an electric field to a tissue, including positioning an electrode within a target tissue region comprising cancerous cells, and applying an alternating electrical current to the target tissue so as to non-thermally ablate cancerous cells of the target tissue region around the electrodes.Type: ApplicationFiled: April 13, 2010Publication date: January 20, 2011Applicant: LaZure Technologies, LLCInventor: Larry Azure
-
Patent number: 7722606Abstract: The present invention provides devices and systems, as well as methods, of electric field delivery and non-thermal or selective ablation of target tissue regions, including selective ablation of cancerous cells and solid tumors. A method of the present invention includes delivering an electric field to a tissue, including positioning an electrode within a target tissue region comprising cancerous cells, and applying an alternating electrical current to the target tissue so as to non-thermally ablate cancerous cells of the target tissue region around the electrodes.Type: GrantFiled: September 14, 2007Date of Patent: May 25, 2010Assignee: LaZúre Technologies, LLCInventor: Larry Azure
-
Publication number: 20100100093Abstract: Methods and systems for delivering electrical energy for controlled heating or hyperthermia to a target tissue of a patient for destruction of cancerous cells or tissue.Type: ApplicationFiled: September 16, 2009Publication date: April 22, 2010Applicant: LaZure Technologies, LLC.Inventor: Larry Azure
-
Patent number: 7680543Abstract: The present invention provides devices and systems, as well as methods, of electric field delivery and ablation (e.g., non-thermal ablation) of target tissues, including cancerous cells and solid tumors. A method of the present invention can include applying an alternating current to a target tissue and removing ablated or liquefied tissue from the target tissue region.Type: GrantFiled: September 14, 2007Date of Patent: March 16, 2010Assignee: LaZure Technologies, LLCInventor: Larry Azure
-
Publication number: 20090076496Abstract: Methods and systems for delivering electrical energy and controlled, mild hyperthermia to a prostate tissue of a patient for destruction of cancerous and/or hyperplastic tissue. A method includes positioning a plurality of electrodes in a target tissue region comprising the prostate tissue, and establishing an alternating electrical current flow through a volume of the prostate tissue to induce mild heating and destruction of cancerous cells in the volume.Type: ApplicationFiled: September 15, 2008Publication date: March 19, 2009Applicant: LaZure Technologies LLC.Inventor: Larry Azure
-
Publication number: 20090076494Abstract: Transurethral systems and methods for delivering electrical energy and controlled, mild heating to a prostate tissue of a patient for destruction of cancerous and/or hyperplastic tissue. A method includes positioning an elongate urethral probe having an expandable member with electrode elements at a target location in the patient's urethra, and inflating or expanding at the target location. Secondary electrodes are positioned within or adjacent to the prostate tissue and spaced from the electrode elements of the expandable member, and an alternating electrical current flow is established between the electrode elements of the expandable member and the one or more secondary electrodes. Current delivery can be selected so as to destroy or ablate cancerous cells of the prostate tissue.Type: ApplicationFiled: September 15, 2008Publication date: March 19, 2009Applicant: LaZure Technologies, LLCInventor: Larry Azure
-
Publication number: 20090076500Abstract: The present invention provides devices and systems, as well as methods, of electric field delivery and non-thermal or mild hyperthermia, and preferential or selective ablation of cancerous cells of target tissue regions. A method can include, for example, advancing a probe comprising a plurality of electrodes to a target tissue region comprising cancerous cells, and deploying the plurality of electrodes from a distal portion of a probe, and applying an alternating current so as to provide one or more electric fields extending through the volume and selectively or preferentially destroy cancerous cells within the volume.Type: ApplicationFiled: September 15, 2008Publication date: March 19, 2009Applicant: LaZure Technologies, LLCInventor: Larry Azure
-
Publication number: 20090076499Abstract: Electric field delivery and ablation of target tissue regions, including cancerous cells and solid tumors. Methods and systems include delivering an electric field to a target tissue, and may include positioning a first electrode or plurality to at least partially define a first treatment volume in the target tissue; positioning a second electrode or plurality to at least partially define a second treatment volume, the first volume is disposed in the second volume; and establishing a first current flow extending through the first volume and a second current flow extending through the second volume.Type: ApplicationFiled: September 15, 2008Publication date: March 19, 2009Applicant: LaZure Technologies, LLC.Inventor: Larry Azure
-
Publication number: 20090076502Abstract: Methods and systems for delivering electrical energy and controlled, mild hyperthermia to a prostate tissue of a patient for destruction of cancerous and/or hyperplastic tissue. A method includes positioning a plurality of electrodes in a target tissue region comprising the prostate tissue, and establishing an alternating electrical current flow through a volume of the prostate tissue to induce mild heating and destruction of cancerous cells in the volume.Type: ApplicationFiled: September 15, 2008Publication date: March 19, 2009Applicants: LaZure Technologies, LLC., LaZure Scientific, Inc.Inventors: Larry Azure, Charles Hill, Andrew L. Azure